CTRN vs REGN
Citi Trends Inc (CTRN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CTRN currently screens at market cap $258.4M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CTRN and REGN stock pages for the full models.
Not investment advice.